Related Experiment Video
Updated: Dec 24, 2025
08:59
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
8.4K
Establishment of a clinically relevant specification for dissolution testing using physiologically based
Takafumi Kato1, Hiroshi Nakagawa2, Tsuyoshi Mikkaichi3
1Formulation Technology Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
Summary
This study establishes a clinically relevant specification (CRS) for drug products using physiologically based pharmacokinetic (PBPK) modeling. This approach ensures drug quality by distinguishing bioequivalent batches and optimizing formulation for safety and efficacy.
Area of Science:
- Pharmacokinetics and Drug Metabolism
- Computational Modeling in Pharmacology
- Pharmaceutical Quality Control
Background:
- Establishing clinically relevant specifications (CRS) is crucial for ensuring drug product quality and performance.
- Distinguishing bioequivalent (BE) from non-BE batches requires robust methods that reflect in vivo performance.
- Physiologically based pharmacokinetic (PBPK) modeling offers a powerful in silico tool for predicting drug behavior.
Purpose of the Study:
- To establish a clinically relevant specification (CRS) for drug products using in silico PBPK modeling.
- To verify the predictive capability of a human PBPK model by comparing simulated and observed pharmacokinetic (PK) data.
- To demonstrate the utility of the verified PBPK model in bioequivalence (BE) simulations for quality control.
Main Methods:
- Construction of a human PBPK model integrating clinical and non-clinical data using GastroPlus™ software.
- Verification of the PBPK model by comparing predicted human PK profiles with observed clinical study data.
- In silico BE simulation studies using dissolution profiles with clinically relevant discriminatory power as input for the PBPK model.
Main Results:
- The developed PBPK model accurately predicted human PK behavior across three different drug formulations.
- Simulated PK profiles closely matched observed PK behavior in clinical studies.
- In silico BE simulations using the verified PBPK model successfully reproduced clinical study outcomes, confirming its ability to detect non-BE batches.
Conclusions:
- A CRS was successfully established using in silico BE simulations with a verified PBPK model.
- This PBPK modeling approach provides a reliable method for detecting and rejecting non-bioequivalent drug product batches.
- The established CRS aids in quality control and optimizing drug formulations for desired PK behavior, safety, and efficacy.
Related Concept Videos
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
128
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
128
01:14Drug Dissolution: Requirements and Profile Comparison
174
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
174
01:13In Vitro Drug Dissolution: Compendial Testing Models I
158
Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
158
01:09In Vitro Drug Dissolution: Compendial Testing Models II
156
Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients,...
156
01:21Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
2.9K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
2.9K
01:26Pharmacokinetic Models: Comparison and Selection Criterion
266
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
266